Tris Pharma, looking to compete with Vertex, reports acute pain trial success

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got lots of news coming out of D.C. today — let’s get straight into it.

Read the rest…